Janusz Sauermann

Janusz Sauermann

Auto-generated profile, based on publicly available information

Janusz Sauermann

Medical University of Lublin

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2026 in Current Problems of Psychiatry
Verified
Journal Article
Open access
PDF file
PNPatrycja Najda
Patrycja Najda
OROliwia Rdzanek
Oliwia Rdzanek
EKEmilia Kamizela
Emilia Kamizela
JSJanusz Sauermann
Janusz Sauermann
SNSylwiusz Niedobylski
Sylwiusz Niedobylski
MPMichał Próchnicki
Michał Próchnicki
Introduction: Schizophrenia represents a leading cause of acute psychotic episodes and is frequently associated with profound social dysfunction and in severe cases, it may result in conditions posing an immediate threat to life. Management typically involves biological treatment modalities combined with psychotherapy; however, a subset of patients develops treatment resistance. Electroconvulsive therapy (ECT) remains a key intervention for overcoming pharmacoresistance, despite its limited availability in Poland. Material and method: The article present a clinical case report and a literature review based on the MEDLINE database. Results: The case study concerns a 20-year-old woman who developed a severe, prolonged psychotic state as a consequence of treatment refusal. Owing to the critical clinical condition, confirmed pharmacoresistance and progressive secondary malnutrition, ECT was initiated as a life-saving measure under the principle of medical necessity. A marked improvement in mental status was observed after the first session. Upon completion of the full ECT course, the patient was discharged home in logical contact, without psychotic symptoms, with a diagnosis of paranoid schizophrenia. Conclusions: The case supports the conclusion that ECT is an effective method for overcoming pharmacoresistance in acute psychosis and may constitute one of the most efficacious therapeutic options. In certain situations, the benefits of ECT outweigh those of pharmacotherapy alone. This case is of particular clinical relevance as it illustrates a life-saving application of ECT. The literature review further confirms the efficacy and safety of this treatment modality. Nevertheless, access to ECT in Poland remains insufficient and excessive ancillary procedural requirements reduce its cost-effectiveness, contributing to the persistence of this limitation.

13 September 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
AJAleksandra Jartych
Aleksandra Jartych
KMKarolina Michalska
Karolina Michalska
IOIzabela Oleksak
Izabela Oleksak
JSJanusz Sauermann
Janusz Sauermann
Anna Jamroz-Wis̈niewskaAnna Jamroz-Wis̈niewska
Anna Jamroz-Wis̈niewska
Konrad RejdakKonrad Rejdak
Konrad Rejdak
We present a case of acute intermittent porphyria (AIP) diagnosed in a pregnant woman with subsequent exacerbation after delivery due to COVID-19 infection. The patient’s symptoms manifested with acute neurovisceral attacks - abdominal pain followed by flaccid quadriparesis, sensory disturbances, hypertension and disturbance in electrolyte levels. The blood plasma test and a 24-hour urine collection revealed increased levels of urine porphobilinogen, 5-aminolevulinic acid and uroporphyrins, which led to the diagnosis of AIP. The patient received i.v. human hemin with positive outcome. After delivery she was again admitted to the hospital due to abdominal pain and trunk hyperesthesia that occurred after a mild course of COVID-19 infection. The second administration of human hemin led to the improvement of the patient's condition. The aim of this case report is to indicate that even with severe risk factors of AIP such as infection and pregnancy, proper diagnostics can increase the chance of quick recovery.